5-Amino-1MQ vs MOTS-c
Updated 7 sources
Key differences
- 15-Amino-1MQ is an oral small molecule that blocks the enzyme NNMT. MOTS-c is an injected peptide that signals through AMPK.
- 2Both are mostly preclinical.
Side by side
Facts from each record, in the same words as their own pages.
| 5-Amino-1MQ | MOTS-c | |
|---|---|---|
| Category |
|
|
| Evidence |
|
|
| FDA status |
|
|
| WADA |
|
|
| Half-life |
|
|
| Routes |
|
|
| Forms | Not reported |
|
| Reported doses |
|
|
| Most cited frequency |
|
|
| Vial sizes |
|
|
| Mixed vial keeps |
|
|
| Protocols on file |
|
|
Doses shown are what sources report, labelled by origin. Not medical advice.
Read each in full
Sources
7 sources, each checked by date. Record updated Oct 23, 2026. Numbers are restated in our own words and labelled by where they came from.
Clinical study2
- Awosemo et al. 2021, LC-MS/MS assay for 5-amino-1-methyl quinolinium in rat plasma: pharmacokinetics and oral bioavailability (J Pharm Biomed Anal)PubMed · checked Oct 23, 2026
- PubMed search: MOTS-c pharmacokinetics or half-lifePubMed · checked Oct 23, 2026
Regulatory4
- FDA briefing document, PCAC July 23 to 24, 2026: MOTS-cFDA · checked Oct 23, 2026
- ClinicalTrials.gov search for 5-amino-1MQ, 5-amino-1-methylquinolinium and NNMT inhibitorClinicalTrials.gov · checked Oct 23, 2026
- FDA Warning Letter 718739, GenoGenix LLC, January 20, 2026FDA · checked Oct 23, 2026
- Interim 503A bulks listFDA · checked Oct 23, 2026
Vendor guide1
- 5-Amino-1MQ vs MOTS-ctrimrx.com · checked Oct 23, 2026